课题基金 / 基金详情

Hematopoietic cytokines for the repair of myocardial infarction

Hematopoietic cytokines for the repair of myocardial infarction
造血细胞因子修复心肌梗塞
批准号:
nhmrc : 332503
负责人:
A/Pr David Curtis
金额:
$22.3万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

A/Pr David Curtis的其他基金

相似基金

相关文献

中文摘要
翻译
心脏病仍然是导致心力衰竭最常见的原因之一。与皮肤或骨髓等其他组织不同,心脏病发作后,心脏无法自我修复。最近,人们认识到骨髓细胞在一定程度上可以修复心脏。这是如何实现的尚不清楚,但它可能是由于新血管的形成,也许是新的心脏肌肉。不幸的是,骨髓细胞的修复不是很有效。提高骨髓细胞修复心脏效率的一种方法是给人骨髓生长因子,增加血液中骨髓细胞的数量,从而增加心脏损伤部位的数量。我们的初步研究表明,尽管修复的效率仍然不足以作为一种有用的治疗方法,但情况就是如此。该项目将研究骨髓生长因子如何改善心脏病发作后的心脏修复,并探索提高修复效率的方法,以便在人体中进行试验。
英文摘要
Heart attacks remain one of the most common causes of heart failure. Unlike many other tissues such as the skin or bone marrow, the heart is unable to repair itself following a heart attack. Recently it has been recognised that bone marrow cells can to a small degree repair the heart. How this is done is not known but it may be due to the formation of new blood vessels and perhaps new heart muscle. Unfortunately, the repair by bone marrow cells is not very efficient. One way of improving the efficiency of heart repair by bone marrow cells is to give people bone marrow growth factors that increase the number of bone marrow cells in the blood and thus, increase the number at the site of heart injury. Our preliminary research shows that this is the case although the efficiency of repair is still not enough as a useful therapy. This project will examine how bone marrow growth factors improve heart repair following heart attacks and explore ways of improving the efficiency of repair to permit trials in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Curing blood cancers: rapid translation from target to drug to clinic
  • 批准号:
    nhmrc : 1139466
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $47.83万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Curtis
  • 依托单位:
Curing blood cancers: rapid translation from target to drug to clinic
  • 批准号:
    nhmrc : GNT1139466
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $64.02万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Curtis
  • 依托单位:
Centre for Blood Transplant and Cell Therapy
  • 批准号:
    nhmrc : GNT1135107
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $250.0万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Curtis
  • 依托单位:
Centre for Blood Transplant and Cell Therapy
  • 批准号:
    nhmrc : 1135107
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $168.96万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Curtis
  • 依托单位:
国内基金
海外基金
基于“肝主泪”和Cytokines/P38MAPK/P53炎症相关通路的养阴润目丸治疗干眼的研究
  • 批准号:
    81674030
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2016
  • 负责人:
    李点
  • 依托单位:
基于“功能药对分析模式”研究逍遥散抗抑郁作用的BDNF/HPA/cytokines靶位整合调节机制
  • 批准号:
    81503277
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    刘蓉
  • 依托单位: